Skip to main content
Heritage Bio Labs · Research use only
Heritage Bio Labs

ACE-031Check methods and identity

What the 2026 marmoset study measured

2 numbered sourcesSource years 2016, 2026

Peptides are short chains of amino acids joined by peptide bonds. Some carry messages that tell cells when to change their activity. ACE-031 is a larger engineered fusion protein. It joins the outer, signal-binding part of human activin receptor type IIB to the Fc region of a human antibody. In a 2026 marmoset study, investigators asked whether intercepting signals such as myostatin and activin A would change how much muscle animals had and how much force that muscle could produce. [1]

The researchers randomly assigned 12 healthy adult marmosets to receive either ACE-031 or a control solution and followed them for 14 weeks. The groups included equal numbers of males and females within each group. Body composition was tracked during the experiment, then muscles were sampled for microscopy and mechanical testing. Lean body mass rose from baseline in the treated group. In the upper-arm muscle sampled at the end, both slow and fast fibers were larger on average than those in controls. The relative share of slow fibers was similar across the two groups. [1]

The force results warrant a careful reading. The team removed a lower-leg muscle and stimulated it in a testing chamber. Specific force, which accounts for muscle size, was higher in treated animals in both single-twitch and sustained-contraction tests. The raw force measurements in those comparisons fell short of statistical significance. The experiment could therefore identify changes in the performance of muscle tissue under controlled conditions. It could not measure walking, fatigue during activity, or performance of a task that requires muscles, nerves and joints to work together. [1]

The authors chose a nonhuman primate partly because the balance of muscle growth regulators differs between rodents and primates. A signal that contributes heavily to growth control in mice may contribute a different share in humans. The marmosets help test whether the biological response extends beyond rodents. The animals were healthy, however, and only four received the control solution. A small study with an isolated muscle endpoint provides limited information about the effects of the same molecule in people with muscle disease. [1]

The older human ACE-031 trial in ambulatory boys with Duchenne muscular dystrophy asked a different question and ended early over potential safety concerns, including nosebleeds and small visibly widened blood vessels. Its walking results remained inconclusive. Taken together, the papers give researchers a reason to examine how different growth signals affect primate muscle and a reason to keep clinical safety and day-to-day movement separate from force produced in a lab. [1] [2]

Sources

Original works cited in this article. Links open the external record in a new tab.

Shop ACE-031

Articles from the Heritage Bio Labs research series, with links to the original sources. For research use only; not medical advice. Also available as Markdown or JSON.